Pituitary Society releases consensus statement on genetic testing in pituitary adenomas
The Pituitary Society published an international consensus statement on genetic testing for patients with pituitary adenomas in Nature Reviews Endocrinology. The authors provided evidence-based recommendations for germline genetic panel testing, covering genes such as AIP, MEN1, CDKN1B, PRKAR1A, and SDH variants. The panel recommended conducting testing within multidisciplinary teams to ensure appropriate pre-test counseling, methodology selection, result interpretation, and patient follow-up. Somatic genetic testing recommendations were also included for clinical scenarios involving aggressive pituitary adenoma types and rarely encountered pituitary carcinomas.
The consensus recommendations aim to standardize germline and somatic genetic testing to guide precision care for patients with pituitary adenomas.
Written by the Genomes desk from the primary source linked above and checked against it. Research use only; not medical advice. Corrections: [email protected].